載入...
Gut microbiome and CAR-T therapy
Considerable progress has been made in cancer therapeutics recently with targeted strategies that are efficacious and less toxic. Immunotherapy and chimeric antigen receptor (CAR) T-cells are increasingly being evaluated in a variety of tumors in the relapsed/refractory as well as frontline disease...
Na minha lista:
| 發表在: | Exp Hematol Oncol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862813/ https://ncbi.nlm.nih.gov/pubmed/31827982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-019-0155-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|